These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 12095408
1. Measuring baroreflex sensitivity from the gain function between arterial pressure and heart period. Pinna GD, Maestri R, Raczak G, La Rovere MT. Clin Sci (Lond); 2002 Jul; 103(1):81-8. PubMed ID: 12095408 [Abstract] [Full Text] [Related]
2. Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques. Maestri R, Pinna GD, Mortara A, La Rovere MT, Tavazzi L. J Am Coll Cardiol; 1998 Feb; 31(2):344-51. PubMed ID: 9462578 [Abstract] [Full Text] [Related]
3. New criteria for estimating baroreflex sensitivity using the transfer function method. Pinna GD, Maestri R. Med Biol Eng Comput; 2002 Jan; 40(1):79-84. PubMed ID: 11954712 [Abstract] [Full Text] [Related]
4. Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure. Davies LC, Francis D, Jurák P, Kára T, Piepoli M, Coats AJ. Clin Sci (Lond); 1999 Oct; 97(4):515-22. PubMed ID: 10491352 [Abstract] [Full Text] [Related]
5. Estimation of baroreflex sensitivity by the bivariate phase rectified signal averaging method: a comparison with the phenylephrine method. Maestri R, La Rovere MT, Raczak G, Danilowicz-Szymanowicz L, Pinna GD. Physiol Meas; 2017 Sep 26; 38(10):1874-1884. PubMed ID: 28885986 [Abstract] [Full Text] [Related]
6. Assessment of baroreflex sensitivity in patients with preserved and impaired left ventricular function by means of the Valsalva manoeuvre and the phenylephrine test. Raczak G, la Rovere MT, Pinna GD, Maestri R, Swiatecka G. Clin Sci (Lond); 2001 Jan 26; 100(1):33-41. PubMed ID: 11115415 [Abstract] [Full Text] [Related]
7. Causal linear parametric model for baroreflex gain assessment in patients with recent myocardial infarction. Nollo G, Porta A, Faes L, Del Greco M, Disertori M, Ravelli F. Am J Physiol Heart Circ Physiol; 2001 Apr 26; 280(4):H1830-9. PubMed ID: 11247798 [Abstract] [Full Text] [Related]
8. Comparison between spectral analysis and the phenylephrine method for the assessment of baroreflex sensitivity in chronic heart failure. Colombo R, Mazzuero G, Spinatonda G, Lanfranchi P, Giannuzzi P, Ponikowski P, Coats AJ, Minuco G. Clin Sci (Lond); 1999 Oct 26; 97(4):503-13. PubMed ID: 10491351 [Abstract] [Full Text] [Related]
9. Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure. La Rovere MT, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Febo O, Pinna GD. J Hypertens; 2011 Aug 26; 29(8):1546-52. PubMed ID: 21666492 [Abstract] [Full Text] [Related]
10. Critical value of baroreflex sensitivity determined by spectral analysis in risk stratification after myocardial infarction. Honzikova N, Fiser B, Semrad B. Pacing Clin Electrophysiol; 2000 Nov 26; 23(11 Pt 2):1965-7. PubMed ID: 11139968 [Abstract] [Full Text] [Related]
11. Limited utility of the phenylephrine-nitroprusside sigmoid curve method of measuring baroreflex function after myocardial infarction. Leitch JW, Newling R, Nyman E, Cox K, Dear K. J Cardiovasc Risk; 1997 Jun 26; 4(3):179-84. PubMed ID: 9475672 [Abstract] [Full Text] [Related]
12. Stability of the noninvasive baroreflex sensitivity assessment using cross-spectral analysis of heart rate and arterial blood pressure variabilities. Wichterle D, Melenovsky V, Necasova L, Kautzner J, Malik M. Clin Cardiol; 2000 Mar 26; 23(3):201-4. PubMed ID: 10761809 [Abstract] [Full Text] [Related]
14. The additional impact of type 2 diabetes on baroreflex sensitivity of coronary artery disease patients might be undetectable in presence of deterioration of mechanical vascular properties. de Oliveira Gois M, Porta A, Simões RP, Kunz VC, Driusso P, Hirakawa HS, De Maria B, Catai AM. Med Biol Eng Comput; 2019 Jul 26; 57(7):1405-1415. PubMed ID: 30843124 [Abstract] [Full Text] [Related]
16. Assessment of baroreflex sensitivity from spontaneous oscillations of blood pressure and heart rate: proven clinical value? Pinna GD, Maestri R, La Rovere MT. Physiol Meas; 2015 Apr 26; 36(4):741-53. PubMed ID: 25798657 [Abstract] [Full Text] [Related]
17. Baroreflex sensitivity in children, adolescents, and young adults with essential and white-coat hypertension. Honzíková N, Nováková Z, Závodná E, Paderová J, Lokaj P, Fiser B, Balcárková P, Hrstková H. Klin Padiatr; 2006 Apr 26; 218(4):237-42. PubMed ID: 16819707 [Abstract] [Full Text] [Related]
18. Cardiovascular variability is similarly altered in coronary patients with normal left ventricular function and in heart failure patients. Radaelli A, Mancia G, Balestri G, Rovati A, Anzuini A, Di Rienzo M, Paolini G, Castiglioni P. J Hypertens; 2014 Nov 26; 32(11):2261-6; discussion 2266. PubMed ID: 25084307 [Abstract] [Full Text] [Related]
19. Cross spectral analysis in assessment of baroreflex gain in patients with coronary artery disease. Airaksinen KE, Tahvanainen KU, Kuusela TA, Huikuri HV, Niemela MJ, Karjalainen P, Eckberg DL. Ann Noninvasive Electrocardiol; 1997 Jul 26; 2(3):229-35. PubMed ID: 11541511 [Abstract] [Full Text] [Related]
20. Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Weston PJ, Panerai RB, McCullough A, McNally PG, James MA, Potter JF, Thurston H, Swales JD. Diabetologia; 1996 Nov 26; 39(11):1385-91. PubMed ID: 8933009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]